Skip to main content
SpringerLink
Log in

Recognising Antibacterial Hypersensitivity In Children

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Adverse reactions to antibacterial agents are not uncommon in children. They are classified as ‘immediate’ or ‘nonimmediate’ according to the time interval between drug administration and onset. Immediate reactions occur within 1 hour and are manifested by urticaria and/or angioedema, bronchospasm and anaphylactic shock; immunological reactions are mediated by IgE antibodies. The main nonimmediate reactions (occuring after more than 1 hour) are maculopapular rash, urticaria and serum sickness; T lymphocytes may participate in maculopapular rash.

Clinical assessment of such reactions is complex. The patient’s history is fundamental; the allergological examination includes in vivo and in vitro tests selected on the basis of the clinical features and the phase of reaction. In the late phase, prick and intradermal tests are sensitive in evaluating β-lactam allergy. Together with delayed-reading intradermal testing, patch testing seems to be useful in diagnosing maculopapular reactions to systemically administered aminopenicillins. Determination of specific IgE levels is the most common in vitro method for diagnosing immediate reactions. In the acute phase, serum tryptase and urinary N-methylhistamine assays are reliable in diagnosing type I pathogenic mechanisms in immediate reactions. Unfortunately, there are few in vitro tests for evaluating other reactions, and most are not fully validated. In selected cases, provocation tests should be performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

References

  1. Anderson JA. Antibiotic drug allergy in children. Curr Opin Pediatr 1994; 6: 656–60

    Article  PubMed  CAS  Google Scholar 

  2. Boguniewicz M, Leung DYM. Hypersensitivity reactions to antibiotics commonly used in children. Pediatr Infect Dis J 1995; 14: 221–31

    Article  PubMed  CAS  Google Scholar 

  3. Patterson R, DeSwarte RD, Greenberger PA, et al. Drug allergy and protocols for management of drug allergies. 2nd ed. Providence (RI): OceanSide Publications, 1995

    Google Scholar 

  4. Blanca M, Vega JM, Garcia J, et al. New aspects of allergic reactions to betalactams: crossreactions and unique specificities. Clin Exp Allergy 1994; 24: 405–15

    Article  Google Scholar 

  5. Sullivan TJ. Allergic reactions to antimicrobial agents: a review of reactions to drugs not in the beta lactam class. J Allergy Clin Immunol 1984; 74: 594–9

    Article  PubMed  CAS  Google Scholar 

  6. VanArsdel Jr PP. Drug allergy: an update. Med Clin North Am 1981; 65: 1089–103

    PubMed  Google Scholar 

  7. De Weck AL. Pharmacologic and immunochemical mechanisms of drug hypersensitivity. Immunol Allergy Clin North Am 1991; 11: 461–74

    Google Scholar 

  8. Adkinson Jr NF. Risk factors for drug allergy. J Allergy Clin Immunol 1984; 74: 567–72

    Article  PubMed  Google Scholar 

  9. Riley RJ, Leeder JS. In vitro analysis of metabolic predisposition to drug hypersensitivity reactions. Clin Exp Immunol 1995; 99: 1–6

    Article  PubMed  CAS  Google Scholar 

  10. Pichler WJ, Schnyder B, Zanni MP, et al. Role of T cells in drugs allergies. Allergy 1998; 53: 225–32

    Article  PubMed  CAS  Google Scholar 

  11. Khan IU, Bickers DR, Haqqi TM, et al. Induction of CYPIA1 mRNA in rat epidermis and cultured human epidermal keratinocytes by benz(a)anthracene and β-naphthoflavone. Drug Metab Dispos 1992; 20: 620–4

    PubMed  CAS  Google Scholar 

  12. Bierman CW, VanArsdsel Jr PP. Penicillin allergy in children: the role of immunological test in its diagnosis. J Allergy 1969; 43: 267–72

    Article  PubMed  CAS  Google Scholar 

  13. VanArsdel Jr PP. Drug reactions: allergy and near-allergy. Ann Allergy 1986; 57: 305–12

    PubMed  CAS  Google Scholar 

  14. Levine BB. Immunologic mechanisms of penicillin allergy: a haptenic model system for the study of allergic diseases of man. N Engl J Med 1966; 275: 1115–25

    Article  PubMed  CAS  Google Scholar 

  15. Saxon A, Beall GN, Rohor AS, et al. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 1987; 107: 204–15

    PubMed  CAS  Google Scholar 

  16. Weiss ME, Adkinson NF. Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Allergy 1988; 18: 515–40

    Article  PubMed  CAS  Google Scholar 

  17. Kunnamo I, Kallio P, Pelkonen P, et al. Serum sickness-like disease is a common cause of acute arthritis in children. Acta Paediatr Scand 1986; 75: 964–9

    Article  PubMed  CAS  Google Scholar 

  18. Platt R, Dreis MW, Kennedy DL, et al. Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin and trimethoprim/sulfamethoxazole. J Infect Dis 1988; 158: 474–6

    Article  PubMed  CAS  Google Scholar 

  19. Alanis A, Weinstein AJ. Adverse reactions associated with the use of oral penicillins and cephalosporins. Med Clin North Am 1983; 67: 113–29

    PubMed  CAS  Google Scholar 

  20. Murray DL, Singer DA, Singer AB, et al. Cefaclor — a cluster of adverse reactions. N Engl J Med 1980; 303: 1003

    PubMed  CAS  Google Scholar 

  21. Levine LR. Quantitative comparison of adverse reactions to cefaclor vs. amoxicillin in a surveillance study. Pediatr Infect Dis J 1985; 4: 358–61

    Article  CAS  Google Scholar 

  22. Herbert AA, Sigman ES, Levy ML. Serum sickness-like reactions from cefaclor in children. J Am Acad Dermatol 1991; 25: 805–8

    Article  Google Scholar 

  23. Parra FM, Igea JM, Martin JA, et al. Serum sickness-like syndrome associated with cefaclor therapy. Allergy 1992; 47: 439–40

    Article  PubMed  CAS  Google Scholar 

  24. Vial T, Pont J, Pham E, et al. Cefaclor-associated serum sickness-like disease: eight cases and review of the literature. Ann Pharmacother 1992; 26: 910–4

    PubMed  CAS  Google Scholar 

  25. Kearns GL, Wheeler JG, Childress SH, et al. Serum sicknesslike reactions to cefaclor: role of hepatic metabolism and individual susceptibility. J Pediatr 1994; 125: 805–11

    Article  PubMed  CAS  Google Scholar 

  26. Kearns GL, Wheeler JG, Rieder MJ, et al. Serum sickness-like reactions to cefaclor: lack of in vitro cross-reactivity with loracarbacef. Clin Pharmacol Ther 1998; 63: 686–93

    Article  PubMed  CAS  Google Scholar 

  27. Lowery N, Kearns GL, Young RA, et al. Serum sickness-like reactions associated with cefprozil therapy. J Pediatr 1994; 126: 325–8

    Google Scholar 

  28. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997; 133: 1224–30

    Article  PubMed  CAS  Google Scholar 

  29. Lawley TJ, Bielory L, Gascon P, et al. Aprospective clinical and immunological analysis of patients with serum sickness. N Engl J Med 1984; 311: 1407–13

    Article  PubMed  CAS  Google Scholar 

  30. Kanwar AJ, Bharjia SC, Belhaj MS. Fixed drug eruptions in children: a series of 23 cases with provocative tests. Dermatologica 1986; 172: 315–8

    Article  PubMed  CAS  Google Scholar 

  31. Sharma VK, Dhar S. Clinical pattern of cutaneous drug eruption among children and adolescents in North India. Pediatr Dermatol 1995; 12: 178–83

    Article  PubMed  CAS  Google Scholar 

  32. Guillaume JC, Roujeau JC, Revuz J, et al. The culprit drugs in 87 cases of toxic epidemial necrolysis (Lyell’s syndrome). Arch Dermatol 1987; 123: 1166–70

    Article  PubMed  CAS  Google Scholar 

  33. Barone CM, Bianchi MA, Lee B, et al. Treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome in children. J Oral Maxillofac Surg 1993; 51: 264–8

    Article  PubMed  CAS  Google Scholar 

  34. Beghetti M, Wilson GJ, Bohn D, et al. Hypersensitivity myocarditis caused by an allergic reaction to cefaclor. J Pediatr 1998; 132: 172–3

    Article  PubMed  CAS  Google Scholar 

  35. Gonzalez FJ, Leyva L, Posadas S, et al. Participation of T lymphocytes in cutaneous allergic reactions to drugs. Clin Exp Allergy 1998; 28Suppl. 4: 3–6

    PubMed  CAS  Google Scholar 

  36. Patterson R. Diagnosis and treatment of drug allergy. J Allergy Clin Immunol 1988; 81: 380–4

    Article  PubMed  CAS  Google Scholar 

  37. Tinkelman DG, Bock A. Anaphylaxis presumed to be caused by beef containing streptomycin. Ann Allergy 1984; 53: 243–4

    PubMed  CAS  Google Scholar 

  38. Abeck D, Kuvert C, Segnini-Torres M, et al. Streptomycin-induced anaphylactic reaction during in vitro fertilization (IVF). Allergy 1994; 49: 388–9

    Article  PubMed  CAS  Google Scholar 

  39. Earl HS, Sullivan TJ. Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics. J Allergy Clin Immunol 1987; 79: 477–83

    Article  PubMed  CAS  Google Scholar 

  40. Anne’ S, Middleton E, Reisman RE. Vancomycin anaphylaxis and successful desensitization. Ann Allergy 1994; 73: 402–4

    PubMed  Google Scholar 

  41. Pascual C, Crespo JF, Quiralte J, et al. In vitro detection of specific antibodies to erythromycin. J Allergy Clin Immunol 1995; 95: 668–71

    Article  PubMed  CAS  Google Scholar 

  42. Barbaud A, Reichert-Penetrat S, Tréchot P, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139: 49–58

    Article  PubMed  CAS  Google Scholar 

  43. Cnudde F, Leynadier F. The diagnosis of allergy to rifampicin confirmed by skin test. Am J Med 1994; 97: 403–4

    Article  PubMed  CAS  Google Scholar 

  44. Cardot E, Tillie-Leblond I, Jeannin P, et al. Anaphylactic reaction to local administration of rifamycin SV. J Allergy Clin Immunol 1995; 95: 1–7

    Article  PubMed  CAS  Google Scholar 

  45. Gruchalla RS, Sullivan TJ. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine. J Allergy Clin Immunol 1991; 88: 784–92

    Article  PubMed  CAS  Google Scholar 

  46. Harle DG, Baldo BA, Smal MA, et al. An immunoassay for the detection of IgE antibodies to trimethoprim in the sera of allergic patients. Clin Allergy 1987; 17: 209–16

    Article  PubMed  CAS  Google Scholar 

  47. Alonso MD, Marcos C, Davila I, et al. Hypersensitivity to trimethoprim. Allergy 1992; 47: 340–2

    Article  PubMed  CAS  Google Scholar 

  48. Cabañas R, Caballero MT, Vega A, et al. Anaphylaxis to trimethoprim. J Allergy Clin Immunol 1996; 97: 137–8

    Article  PubMed  Google Scholar 

  49. Van Ginkel CJ, Bruintjes TD, Huizing EH. Allergy due to topical medications in chronic otitis externa and chronic otitis media. Clin Otolaryngol 1995; 20: 326–8

    Article  PubMed  Google Scholar 

  50. de Haan P, Bruynzeel DP, Van Ketel WG. Onset of penicillin rashes: relation between type of penicillin administered and type of immune reactivity. Allergy 1986; 41: 75–8

    Article  PubMed  Google Scholar 

  51. Romano A, Di Fonso M, Papa G, et al. Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes. Allergy 1995; 50: 113–8

    Article  PubMed  CAS  Google Scholar 

  52. Romano A, De Santis A, Romito A, et al. Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes. Ann Allergy Asthma Immunol 1998; 80: 533–7

    Article  Google Scholar 

  53. Romano A, Quaratino D, Papa G, et al. A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins. J Allergy Clin Immunol 1999; 103: 1186–90

    Article  PubMed  CAS  Google Scholar 

  54. Romano A, Quaratino D, Papa G, et al. Aminopenicillin allergy. Arch Dis Child 1997; 76: 513–7

    Article  PubMed  CAS  Google Scholar 

  55. Romano A, Pietrantonio F, Di Fonso M, et al. Delayed hypersensitivity to cefuroxime. Contact Dermatitis 1992; 27: 270–1

    Article  PubMed  CAS  Google Scholar 

  56. Alanko K. Topical provocation of fixed drug eruption: a study of 30 patients. Contact Dermatitis 1994; 31: 25–7

    Article  PubMed  CAS  Google Scholar 

  57. Lee AY. Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years. Contact Dermatitis 1998; 38: 258–60

    Article  PubMed  CAS  Google Scholar 

  58. Harle DG, Baldo BA. Drugs as allergens: an immunoassay for detecting IgE antibodies to cephalosporins. Int Arch Allergy Appl Immunol 1990; 92: 439–44

    Article  PubMed  CAS  Google Scholar 

  59. Igea JM, Fraj J, Davila I, et al. Allergy to cefazolin: study of in vivo cross reactivity with other betalactams. Ann Allergy 1992; 68: 515–9

    PubMed  CAS  Google Scholar 

  60. Pham NH, Baldo BA. β-Lactam drug allergens: fine structural recognition patterns of cephalosporin-reactive IgE antibodies. J Molec Recogn 1996; 9: 287–96

    Article  CAS  Google Scholar 

  61. Romano A, Quaratino D, Aimone-Gastin I, et al. Cephalosporin allergy: characterization of unique and cross-reacting cephalosporin antigens. Int J Immunopathol Pharmacol 1997; 10Suppl. 2: 187–91

    Google Scholar 

  62. Carrington DM, Earl HS, Sullivan TJ. Studies of human IgE to a sulfonamide determinant. J Allergy Clin Immunol 1987; 79: 442–7

    Article  PubMed  CAS  Google Scholar 

  63. Harle DG, Baldo BA, Wells JV. Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole. Mol Immunol 1988; 25: 1347–54

    Article  PubMed  CAS  Google Scholar 

  64. Smal MA, Baldo BA, Harle DG. Drug as allergens: the molecule basis of IgE binding to trimethoprim. Allergy 1988; 43: 184–91

    Article  PubMed  CAS  Google Scholar 

  65. Pham NH, Baldo BA, Manfredi M, et al. Fine structural specificity differences of trimethoprim allergenic determinants. Clin Exp Allergy 1996; 26: 1155–60

    Article  PubMed  CAS  Google Scholar 

  66. Kraft D, Roth A, Mischer P, et al. Specific and total serum IgE measurements in the diagnosis of penicillin allergy: a long term follow-up study. Clin Allergy 1977; 7: 21–8

    Article  PubMed  CAS  Google Scholar 

  67. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997; 27: 175–81

    Article  PubMed  CAS  Google Scholar 

  68. Merk H, Baron J, Kawakubo Y, et al. Metabolites and allergic drug reactions. Clin Exp Allergy 1998; 28Suppl. 4: 21–4

    PubMed  CAS  Google Scholar 

  69. Stephan V, Zimmermann A, Kühr J, et al. Determination of N-methylhistamine in urine as an indicator of histamine release in immediate allergic reactions. J Allergy Clin Immunol 1990; 86: 862–8

    Article  PubMed  CAS  Google Scholar 

  70. Schwartz LB, Metcalfe DD, Miller JS, et al. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316: 1622–6

    Article  PubMed  CAS  Google Scholar 

  71. Schwartz LB, Yunginger JW, Miller J, et al. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989; 83: 1551–5

    Article  PubMed  CAS  Google Scholar 

  72. Quinley ED. Immunohematology principles and practice. 2nd ed. Philadelphia: Lippincott, 1998

    Google Scholar 

  73. Gonzalez FJ, Carvajal MJ, Juarez C, et al. Expression of cutaneous lymphocyte associated antigen in circulating T cells in drug allergic reactions. Int Arch Allergy Immunol 1997; 113: 345–7

    Article  PubMed  CAS  Google Scholar 

  74. Santamaria Babi LF, Moser R, Perez Soler MT, et al. Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J Immunol 1995; 154: 1543–50

    PubMed  CAS  Google Scholar 

  75. Warrington RJ, Simons FER, Ho HW, et al. Diagnosis of penicillin allergy by skin testing: the Manitoba experience. Can Med Assoc J 1978; 118: 787–91

    PubMed  CAS  Google Scholar 

  76. Chandra RK, Joglekar SA, Tomas E. Penicillin allergy: anti-penicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin. Arch Dis Child 1980; 55: 857–60

    Article  PubMed  CAS  Google Scholar 

  77. Mendelson LM, Ressler C, Rosen JP, et al. Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization. J Allergy Clin Immunol 1984; 73: 76–81

    Article  PubMed  CAS  Google Scholar 

  78. Blanca M. Allergic reactions to penicillins: a changing world? Allergy 1995; 50: 777–82

    Article  PubMed  CAS  Google Scholar 

  79. Van Dellen RG, Walsh WE, Peters GA, et al. Differing patterns of wheal and flare skin reactivity in patients allergic to the penicillins. J Allergy 1971; 47: 230–6

    PubMed  Google Scholar 

  80. Solley GO, Gleich GJ, Van Dellen RG. Penicillin allergy: clinical experience with a battery of skin-test reagents. J Allergy Clin Immunol 1982; 69: 238–44

    Article  PubMed  CAS  Google Scholar 

  81. Moss RB, Babin S, Hsu YP, et al. Allergy to semisynthetic penicillins in cystic fibrosis. J Pediatr 1984; 104: 460–6

    Article  PubMed  CAS  Google Scholar 

  82. Cherry JD. Cutaneous manifestations of systemic infections. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. 2nd ed. Philadelphia: Saunders, 1987: 786–817

    Google Scholar 

  83. Mortureux P, Léautè-Labrèze C, Legrain-Lifermann V, et al. Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol 1998; 134: 319–23

    Article  PubMed  CAS  Google Scholar 

  84. Graff-Lonnevig V, Hedlin G, Lindfors A. Penicillin allergy: a rare paedriatic condition? Arch Dis Child 1988; 63: 1342–6

    Article  PubMed  CAS  Google Scholar 

  85. Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr 1998; 132: 137–43

    Article  PubMed  CAS  Google Scholar 

  86. Finke SR, Grieco MH, Connell JT, et al. Results of comparative skin tests with penicilloyl-polylysine and penicillin in patients with penicillin allergy. Am J Med 1965; 38: 71–82

    Article  PubMed  CAS  Google Scholar 

  87. Green GR, Rosenblum AH, Sweet LC. Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. J Allergy Clin Immunol 1977; 60: 339–45

    Article  PubMed  CAS  Google Scholar 

  88. Sullivan TJ, Wedner HJ, Shatz JS, et al. Skin testing to detect penicillin allergy. J Allergy Clin Immunol 1981; 68: 171–80

    Article  PubMed  CAS  Google Scholar 

  89. Blanca M, Torres MJ, Garcia JJ, et al. Natural evolution of skin test sensitivity in patients allergic to β-lactam antibiotics. J Allergy Clin Immunol 1999; 103: 918–24

    Article  PubMed  CAS  Google Scholar 

  90. Aihara M, Ikezawa Z. Evaluation of the skin test reactions with delayed type rash induced by penicillins and cephalosporins. J Dermatol 1987; 14: 440–8

    PubMed  CAS  Google Scholar 

  91. Vega JM, Blanca M, Carmona MJ, et al. Delayed allergic reactions to betalactams. Allergy 1991; 46: 154–7

    Article  PubMed  CAS  Google Scholar 

  92. Warrington RJ, Silviu-Dan F, Magro C. Accelerated cell-mediated immune reactions in penicillin allergy. J Allergy Clin Immunol 1993; 92: 626–8

    Article  PubMed  CAS  Google Scholar 

  93. Terrados S, Blanca M, Garcia J, et al. Nonimmediate reactions to betalactams: prevalence and role of the different penicillins. Allergy 1995; 50: 563–7

    Article  PubMed  CAS  Google Scholar 

  94. Barbaud AM, Béné MC, Schmutz JL, et al. Role of delayed cellular hypersensitivity and adhesion molecules in amoxicillin-induced morbilliform rashes. Arch Dermatol 1997; 133: 481–6

    Article  PubMed  CAS  Google Scholar 

  95. Castro MS, Schwartz RH, Nazarian LF. Ampicillin and amoxicillin delayed hypersensitivity: side-chain-specific allergic reactions in a child. Pediatr Asthma Allergy Immunol 1996; 10: 197–203

    Article  Google Scholar 

  96. Chosidow O, Bourgault I, Roujeau JC. Drug rashes: what are the targets of cell-mediated cytotoxicity? Arch Dermatol 1994; 130: 627–9

    Article  PubMed  CAS  Google Scholar 

  97. Haverkos HV, Amsel Z, Drotman P. Adverse virus-drug interactions. Rev Infect Dis 1991; 13: 697–704

    Article  PubMed  CAS  Google Scholar 

  98. Baum H, Butler P, Davies H, et al. Autoimmune diseases and molecular mimicry: an hypothesis. Trends Biochem Sci 1993; 4: 140–4

    Article  Google Scholar 

  99. Romano A. Delayed hypersensitivity to aminopenicillins. Clin Exp Allergy 1998; 28Suppl. 4: 29–32

    PubMed  CAS  Google Scholar 

  100. Norrby SR. Side effects of cephalosporins. Drugs 1987; Suppl. 2: 105–20

    Google Scholar 

  101. Lin RY. A perspective on penicillin allergy. Arch Intern Med 1992; 152: 930–7

    Article  PubMed  CAS  Google Scholar 

  102. Perkins RL, Saslaw S. Experiences with cephalothin. Ann Intern Med 1966; 64: 13–24

    PubMed  CAS  Google Scholar 

  103. Pedersen-Bjergaard J. Cephalothin in the treatment of penicillin sensitive patients. Acta Allergol 1967; 22: 299–306

    Google Scholar 

  104. Girard J-P. Common antigenic determinants of penicillin G, ampicillin and the cephalosporins demonstrated in men. Int Arch Allergy 1968; 33: 428–38

    Article  PubMed  CAS  Google Scholar 

  105. Assem ESK, Vickers MR. Tests for penicillin allergy in man. II. The immunological cross-reaction between penicillins and cephalosporins. Immunology 1974; 27: 255–69

    PubMed  CAS  Google Scholar 

  106. Blanca M, Fernandez J, Miranda A, et al. Cross-reactivity between penicillins and cephalosporins: clinical and immunologic studies. J Allergy Clin Immunol 1989; 83: 381–5

    Article  PubMed  CAS  Google Scholar 

  107. Audicana M, Bernaola G, Urrutia I, et al. Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin. Allergy 1994; 49: 108–13

    Article  PubMed  CAS  Google Scholar 

  108. Anne’ S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995; 74: 167–70

    Google Scholar 

  109. Shapiro LE, Knowles SR, Shear NH. Sulfonamide allergies: management in the nineties. ACI Int 1996; 8: 5–8

    Google Scholar 

  110. Uhari M, Nuutinen M, Turtinen J. Adverse reactions in children during long term antimicrobial therapy. Pediatr Infect Dis J 1996; 15: 404–8

    Article  PubMed  CAS  Google Scholar 

  111. Kalish RS, LaPorte A, Wood JA, et al. Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. J Allergy Clin Immunol 1994; 94: 465–72

    Article  PubMed  CAS  Google Scholar 

  112. Mauri-Hellweg D, Bettens F, Mauri D, et al. Activation of drug-specific CD4+ and CD8+ in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995; 155: 462–72

    PubMed  CAS  Google Scholar 

  113. Rieder MJ, Uetrecht J, Shear NH, et al. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro rechallenge with hydroxylamine metabolites. Ann Intern Med 1989; 110: 286–9

    PubMed  CAS  Google Scholar 

  114. Rieder MJ, Shear NH, Kanee A, et al. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther 1991; 49: 13–7

    Article  PubMed  CAS  Google Scholar 

  115. Zielinska E, Niewiarowski W, Bodalski J, et al. Genotyping of the arylamine N-acetyltransferase polymorphism in the prediction of idiosyncratic reactions to trimethoprim-sulfamethoxazole in infants. Pharm World Sci 1998; 20: 123–30

    Article  PubMed  CAS  Google Scholar 

  116. Coopman SA, Johnson RA, Platt R, et al. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670–4

    Article  PubMed  CAS  Google Scholar 

  117. Chanock SJ, Luginbuhl LM, Mclntosh KM, et al. Life-threatening reaction to trimethoprim/sulfamethoxazole in pediatric human immunodeficiency virus infection. Pediatrics 1994; 93: 519–21

    PubMed  CAS  Google Scholar 

  118. van der Ven AJAM, Koopmans PP, Vree TB, et al. Adverse reactions to co-trimoxazole in HIV infection. Lancet 1991; 338: 431–3

    Article  PubMed  Google Scholar 

  119. Koopmans PP, van der Ven AJAM, Vree TB, et al. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic? AIDS 1995; 9: 217–22

    PubMed  CAS  Google Scholar 

  120. Gruchalla RS, Pesenko RD, Do TT, et al. Sulfonamide-induced reactions in desensitized patients with AIDS — the role of covalent protein haptenation by sulfamethoxazole. J Allergy Clin Immunol 1998; 101: 371–8

    Article  PubMed  CAS  Google Scholar 

  121. Slater JE. Hypersensitivity to macrolide antibiotics. Ann Allergy 1991; 66: 193–5

    PubMed  CAS  Google Scholar 

  122. Igea JM, Quirce S, de la Hoz B, et al. Adverse cutaneous reactions due to macrolides. Ann Allergy 1991; 66: 216–8

    PubMed  CAS  Google Scholar 

  123. Treadway C, Pontani D. Paediatric safety of azithromycin: worldwide experience. J Antimicrob Chemother 1996; 37Suppl. C: 143–9

    Article  PubMed  CAS  Google Scholar 

  124. Craft JC, Siepman N. Overview of the safety profile of clarithromycin suspension in pediatric patients. Pediatr Infect Dis J 1993; 12: S142–7

    Article  PubMed  CAS  Google Scholar 

  125. Kamada MM, Twarog F, Leung DYM. Multiple antibiotic sensitivity in a pediatric population. Allergy Proc 1991; 12: 347–60

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Geriatrics, UCSC - Allergy Unit, C.I. Columbus, Rome, Italy

    Antonino Romano

  2. IRCCS Oasi Maria S.S., Troina, Italy

    Antonino Romano

Authors
  1. Antonino Romano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonino Romano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romano, A. Recognising Antibacterial Hypersensitivity In Children. Pediatr-Drugs 2, 101–112 (2000). https://doi.org/10.2165/00148581-200002020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00148581-200002020-00003

Keywords

Search

Navigation